Altrinsic Global Advisors LLC Morphic Holding, Inc. Transaction History

Altrinsic Global Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $2.48 Million - $3.56 Million	-68,485 Closed	0 $0
Q1 2021 May 14, 2021	BUY	$29.77 - $84.85 $595,400 - $1.7 Million	20,000 Added 41.25%	68,485 $4.33 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $128,300 - $172,750	5,000 Added 11.5%	48,485 $1.63 Million
Q2 2020 Aug 14, 2020	BUY	$12.65 - $29.57 $170,585 - $398,751	13,485 Added 44.95%	43,485 $1.18 Million
Q1 2020 May 14, 2020	BUY	$10.84 - $20.85 $325,200 - $625,500	30,000 New	30,000 $440,000

4.96M

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $2.19B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

Get notified when there are updates to the investment portfolio of Altrinsic Global Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Altrinsic Global Advisors LLC with notifications on news.